|
| | Issue Date | Title | Author(s) |
| 1 | 2023 | Design, Molecular Modelling and Synthesis of Novel Benzothiazole Derivatives as BCL-2 inhibitors | Ismail, Hoda S.; Khalil, Amira; Taha, Rabah A.; Lasheen, Deena S. ; Abou El Ella, Dalal |
| 2 | Dec-2022 | Design, synthesis, and biological evaluation of new thieno[2,3-d] pyrimidine derivatives as targeted therapy for PI3K with molecular modelling study | Elmenier, Fatma M; Lasheen, Deena ; Abouzid, Khaled |
| 3 | Dec-2022 | Molecular design, synthesis and biological evaluation of novel 1,2,5-trisubstituted benzimidazole derivatives as cytotoxic agents endowed with ABCB1 inhibitory action to overcome multidrug resistance in cancer cells | Abdelhafiz, Abeer H A; Serya, Rabah A T; Lasheen, Deena S. ; Wang, Nessa; Sobeh, Mansour; Wink, Michael; Abouzid, Khaled |
| 4 | 8-Mar-2022 | Identification of novel furo[2,3-d]pyrimidine based chalcones as potent anti-breast cancer agents: synthesis, in vitro and in vivo biological evaluation | Mansour, Mai A; Oraby, Mamdouh A; Muhammad, Zeinab A; Lasheen, Deena ; Gaber, Hatem M; Khaled A M Abouzid |
| 5 | 5-Oct-2021 | Novel benzenesulfonamides aryl and arylsulfone conjugates adopting tail/dual tail approaches: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies | Eldeeb, Assem H; Abo-Ashour, Mahmoud F; Angeli, Andrea; Bonardi, Alessandro; Elrazaz, Eman ; Nocentini, Alessio; Gratteri, Paola; Abdel-Aziz, Hatem A; Supuran, Claudiu T; Lasheen, Deena S. |
| 6 | 26-Aug-2020 | Elaborating piperazinyl-furopyrimidine based scaffolds as phosphoinositol-3-kinase enzyme alpha (PI3Kα) inhibitors to combat pancreatic cancer | Mansour, Mai A; Lasheen, Deena S. ; Gaber, Hatem M; Khaled A M Abouzid |
| 7 | Aug-2020 | Scaffold hopping and redesign approaches for quinazoline based urea derivatives as potent VEGFR-2 inhibitors | Hadi, Soha R Abd El; Soliman, Dalia H; Elrazaz, Eman ; Khaled A M Abouzid ; Lasheen, Deena S. |
| 8 | 1-Dec-2019 | Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer | Elmenier, Fatma M; Lasheen, Deena S. ; Khaled A M Abouzid |
| 9 | Dec-2019 | Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition | Elmeligie, Salwa; Aboul-Magd, Asmaa M; Lasheen, Deena S. ; Ibrahim, Tamer M; Abdelghany, Tamer M; Khojah, Sohair M |
| 10 | Aug-2019 | 3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation | Sobhy, Mahitab K; Mowafy, Samar; Lasheen, Deena S. ; Farag, Nahla A; Khaled A M Abouzid |
| 11 | 2019 | Apoptosis in cancer: from pathogenesis to discovery of advanced selective Bcl-2 family inhibitors | Abbas, Samaa; Abdou, Nermin; Lasheen, Deena S. ; Abou El Ella, Dalal |
| 12 | Dec-2018 | Identification of new pyrrolo[2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling | Adel, Mai; Serya, Rabah ; Lasheen, Deena S. ; Khaled A M Abouzid |
| 13 | Sep-2018 | Pyrrolopyrimidine, A Multifaceted Scaffold in Cancer Targeted Therapy | Adel, Mai; Serya, Rabah A T; Lasheen, Deena S. ; Abouzid, Khaled |
| 14 | Sep-2018 | Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer | Hesham, Heba M; Lasheen, Deena S. ; Khaled A M Abouzid |
| 15 | 15-Jul-2018 | Synthesis and biological evaluation of novel 2-oxo-1,2-dihydroquinoline-4-carboxamide derivatives for the treatment of esophageal squamous cell carcinoma | Shahin, Mai I; Roy, Joyeeta; Hanafi, Maha; Wang, Dongyao; Luesakul, Urarika; Chai, Yifeng; Muangsin, Nongnuj; Lasheen, Deena S. ; Neamati, Nouri; Khaled A M Abouzid ; Abou El Ella, Dalal |
| 16 | 15-Jul-2018 | Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors | Milik, Sandra N; Abdel-Aziz, Amal Kamal; Serya, Rabah ; Minucci, Saverio; Lasheen, Deena S. ; Khaled A M Abouzid |
| 17 | 1-Jun-2018 | Design, synthesis and 3D QSAR based pharmacophore study of novel imatinib analogs as antitumor-apoptotic agents | Fawzy, Iten M; Youssef, Khairia M; Lasheen, Deena S. ; Ismail, Nasser Sm; Abouzid, Khaled |
| 18 | 2018 | Imidazo[2',1':2,3]thiazolo[4,5-d]pyridazinone as a new scaffold of DHFR inhibitors: Synthesis, biological evaluation and molecular modeling study | Ewida, Menna A; Abou El Ella, Dalal ; Lasheen, Deena S. ; Ewida, Heba A; El-Gazzar, Yomna I; El-Subbagh, Hussein I |
| 19 | 2018 | Design, synthesis, molecular docking study, and biological evaluation of salicylaldimine derivatives as potential histone deacetylases inhibitors (HDACi) and anticancer agents | Hesham, Heba; Lasheen, Deena S. ; Abouzid, Khaled |
| 20 | Oct-2017 | Thiazolo[4,5-d]pyridazine analogues as a new class of dihydrofolate reductase (DHFR) inhibitors: Synthesis, biological evaluation and molecular modeling study | Ewida, Menna A; Abou El Ella, Dalal ; Lasheen, Deena S. ; Ewida, Heba A; El-Gazzar, Yomna I; El-Subbagh, Hussein I |
Loading...
2
0
20
0
false
